202 related articles for article (PubMed ID: 26419344)
21. Recent developments in skin mimic systems to predict transdermal permeation.
Waters LJ
Curr Pharm Des; 2015; 21(20):2725-32. PubMed ID: 25925123
[TBL] [Abstract][Full Text] [Related]
22. Delivering drugs by the transdermal route: review and comment.
Tanner T; Marks R
Skin Res Technol; 2008 Aug; 14(3):249-60. PubMed ID: 19159369
[TBL] [Abstract][Full Text] [Related]
23. Iontophoretic drug delivery.
Kalia YN; Naik A; Garrison J; Guy RH
Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
[TBL] [Abstract][Full Text] [Related]
24. Current pharmaceutical design on adhesive based transdermal drug delivery systems.
Ghosh A; Banerjee S; Kaity S; Wong TW
Curr Pharm Des; 2015; 21(20):2771-83. PubMed ID: 25925119
[TBL] [Abstract][Full Text] [Related]
25. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
[TBL] [Abstract][Full Text] [Related]
26. Chemical penetration enhancers: a patent review.
Ahad A; Aqil M; Kohli K; Chaudhary H; Sultana Y; Mujeeb M; Talegaonkar S
Expert Opin Ther Pat; 2009 Jul; 19(7):969-88. PubMed ID: 19552513
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and therapeutic applications of iontophoresis.
Sieg A; Wascotte V
J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
[TBL] [Abstract][Full Text] [Related]
28. In vitro/in vivo correlations in transdermal product development.
Ghosh P; Milewski M; Paudel K
Ther Deliv; 2015; 6(9):1117-24. PubMed ID: 26419538
[TBL] [Abstract][Full Text] [Related]
29. [Transdermal therapeutic systems for drug administration].
Hupfeld S; Gravem H
Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
[TBL] [Abstract][Full Text] [Related]
30. What is the future of heated transdermal delivery systems?
Otto DP; de Villiers MM
Ther Deliv; 2014; 5(9):961-4. PubMed ID: 25375338
[No Abstract] [Full Text] [Related]
31. Transdermal drug delivery in vitro using diffusion cells.
Bartosova L; Bajgar J
Curr Med Chem; 2012; 19(27):4671-7. PubMed ID: 22934776
[TBL] [Abstract][Full Text] [Related]
32. Liposomes and skin: from drug delivery to model membranes.
El Maghraby GM; Barry BW; Williams AC
Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
[TBL] [Abstract][Full Text] [Related]
33. Adhesive properties: a critical issue in transdermal patch development.
Cilurzo F; Gennari CG; Minghetti P
Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
[TBL] [Abstract][Full Text] [Related]
34. Heat effects on drug delivery across human skin.
Hao J; Ghosh P; Li SK; Newman B; Kasting GB; Raney SG
Expert Opin Drug Deliv; 2016; 13(5):755-68. PubMed ID: 26808472
[TBL] [Abstract][Full Text] [Related]
35. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery.
Wong TW
J Control Release; 2014 Nov; 193():257-69. PubMed ID: 24801250
[TBL] [Abstract][Full Text] [Related]
36. Cell-penetrating peptides as a novel transdermal drug delivery system.
Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
[TBL] [Abstract][Full Text] [Related]
37. Special Focus Issue: Transdermal, Topical and Folicular Drug Delivery Systems.
McConville J
Drug Dev Ind Pharm; 2016; 42(6):845. PubMed ID: 27031915
[No Abstract] [Full Text] [Related]
38. Skin penetration enhancers.
Lane ME
Int J Pharm; 2013 Apr; 447(1-2):12-21. PubMed ID: 23462366
[TBL] [Abstract][Full Text] [Related]
39. Electrically-assisted transdermal drug delivery.
Riviere JE; Heit MC
Pharm Res; 1997 Jun; 14(6):687-97. PubMed ID: 9210183
[TBL] [Abstract][Full Text] [Related]
40. Transdermal drug delivery system: patent reviews.
Samad A; Ullah Z; Alam MI; Wais M; Shams MS
Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):143-52. PubMed ID: 19519574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
